SELLAS Life Sciences Group, Inc. (SLS)

5.505 +0.20 (+3.67%) USD  |  NASDAQ  |  Mar 04, 15:14
More

SELLAS Life Sciences Group Stock Based Compensation (Annual Per Share)

Stock Based Compensation (Annual Per Share) Chart

View Stock Based Compensation (Annual Per Share) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual Per Share) Range, Past 5 Years

View Stock Based Compensation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual Per Share) Benchmarks

View Stock Based Compensation (Annual Per Share) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. --
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade